BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 18639541)

  • 1. Effects of lactone derivatives on aromatase (CYP19) activity in H295R human adrenocortical and (anti)androgenicity in transfected LNCaP human prostate cancer cells.
    Sanderson T; Renaud M; Scholten D; Nijmeijer S; van den Berg M; Cowell S; Guns E; Nelson C; Mutarapat T; Ruchirawat S
    Eur J Pharmacol; 2008 Sep; 593(1-3):92-8. PubMed ID: 18639541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction and inhibition of aromatase (CYP19) activity by natural and synthetic flavonoid compounds in H295R human adrenocortical carcinoma cells.
    Sanderson JT; Hordijk J; Denison MS; Springsteel MF; Nantz MH; van den Berg M
    Toxicol Sci; 2004 Nov; 82(1):70-9. PubMed ID: 15319488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiandrogenic effects of novel androgen synthesis inhibitors on hormone-dependent prostate cancer.
    Long BJ; Grigoryev DN; Nnane IP; Liu Y; Ling YZ; Brodie AM
    Cancer Res; 2000 Dec; 60(23):6630-40. PubMed ID: 11118046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1α,25-Dihydroxyvitamin D3 exerts tissue-specific effects on estrogen and androgen metabolism.
    Lundqvist J; Norlin M; Wikvall K
    Biochim Biophys Acta; 2011 Apr; 1811(4):263-70. PubMed ID: 21262387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Neonicotinoids on Promoter-Specific Expression and Activity of Aromatase (CYP19) in Human Adrenocortical Carcinoma (H295R) and Primary Umbilical Vein Endothelial (HUVEC) Cells.
    Caron-Beaudoin É; Denison MS; Sanderson JT
    Toxicol Sci; 2016 Jan; 149(1):134-44. PubMed ID: 26464060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemopreventive actions by enterolactone and 13 VIOXX-related lactone derivatives in H295R human adrenocortical carcinoma cells.
    van Duursen MB; Nijmeijer SM; Ruchirawat S; van den Berg M
    Toxicol Lett; 2010 Feb; 192(3):271-7. PubMed ID: 19913079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen-dependent growth regulation of and release of specific protein(s) by the androgen receptor containing human prostate tumor cell line LNCaP.
    Berns EM; de Boer W; Mulder E
    Prostate; 1986; 9(3):247-59. PubMed ID: 2946029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of bisphenol A-related diphenylalkanes on vitellogenin production in male carp (Cyprinus carpio) hepatocytes and aromatase (CYP19) activity in human H295R adrenocortical carcinoma cells.
    Letcher RJ; Sanderson JT; Bokkers A; Giesy JP; van den Berg M
    Toxicol Appl Pharmacol; 2005 Dec; 209(2):95-104. PubMed ID: 15907334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction and inhibition of aromatase (CYP19) activity by various classes of pesticides in H295R human adrenocortical carcinoma cells.
    Sanderson JT; Boerma J; Lansbergen GW; van den Berg M
    Toxicol Appl Pharmacol; 2002 Jul; 182(1):44-54. PubMed ID: 12127262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Forskolin up-regulates aromatase (CYP19) activity and gene transcripts in the human adrenocortical carcinoma cell line H295R.
    Watanabe M; Nakajin S
    J Endocrinol; 2004 Jan; 180(1):125-33. PubMed ID: 14709151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclooxygenase-2 directly regulates gene expression of P450 Cyp19 aromatase promoter regions pII, pI.3 and pI.7 and estradiol production in human breast tumor cells.
    Prosperi JR; Robertson FM
    Prostaglandins Other Lipid Mediat; 2006 Oct; 81(1-2):55-70. PubMed ID: 16997132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgens up-regulate the insulin-like growth factor-I receptor in prostate cancer cells.
    Pandini G; Mineo R; Frasca F; Roberts CT; Marcelli M; Vigneri R; Belfiore A
    Cancer Res; 2005 Mar; 65(5):1849-57. PubMed ID: 15753383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of aromatase activity and mRNA by various selected pesticides in the human choriocarcinoma JEG-3 cell line.
    Laville N; Balaguer P; Brion F; Hinfray N; Casellas C; Porcher JM; Aït-Aïssa S
    Toxicology; 2006 Nov; 228(1):98-108. PubMed ID: 16996190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiandrogenic and growth inhibitory effects of ring-substituted analogs of 3,3'-diindolylmethane (ring-DIMs) in hormone-responsive LNCaP human prostate cancer cells.
    Abdelbaqi K; Lack N; Guns ET; Kotha L; Safe S; Sanderson JT
    Prostate; 2011 Sep; 71(13):1401-12. PubMed ID: 21321979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth inhibition of human prostate cells in vitro by novel inhibitors of androgen synthesis.
    Klus GT; Nakamura J; Li JS; Ling YZ; Son C; Kemppainen JA; Wilson EM; Brodie AM
    Cancer Res; 1996 Nov; 56(21):4956-64. PubMed ID: 8895750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiestrogens upregulate estrogen receptor beta expression and inhibit adrenocortical H295R cell proliferation.
    Montanaro D; Maggiolini M; Recchia AG; Sirianni R; Aquila S; Barzon L; Fallo F; Andò S; Pezzi V
    J Mol Endocrinol; 2005 Oct; 35(2):245-56. PubMed ID: 16216906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene profiling and promoter reporter assays: novel tools for comparing the biological effects of botanical extracts on human prostate cancer cells and understanding their mechanisms of action.
    Bigler D; Gulding KM; Dann R; Sheabar FZ; Conaway MR; Theodorescu D
    Oncogene; 2003 Feb; 22(8):1261-72. PubMed ID: 12606954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition and induction of aromatase (CYP19) activity by brominated flame retardants in H295R human adrenocortical carcinoma cells.
    Cantón RF; Sanderson JT; Letcher RJ; Bergman A; van den Berg M
    Toxicol Sci; 2005 Dec; 88(2):447-55. PubMed ID: 16177243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new luciferase reporter gene assay for the detection of androgenic and antiandrogenic effects based on a human prostate specific antigen promoter and PC3/AR human prostate cancer cells.
    Kizu R; Otsuki N; Kishida Y; Toriba A; Mizokami A; Burnstein KL; Klinge CM; Hayakawai K
    Anal Sci; 2004 Jan; 20(1):55-9. PubMed ID: 14753257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of steroid glucuronosyltransferase activities and transcripts by androgen in the human prostatic cancer LNCaP cell line.
    Guillemette C; Hum DW; Bélanger A
    Endocrinology; 1996 Jul; 137(7):2872-9. PubMed ID: 8770908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.